One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Pharmaceutical Analytical Testing Market

[ 英語タイトル ] Pharmaceutical Analytical Testing Market- Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0089372
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 117
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Laboratory Testing Inc.
- Eurofins Scientific
- Toxikon Inc.
- Pace Analytical Services
- Intertek Phamaceutical Services
- Boston Analytical
- West Pharmaceutical Services Inc.
- Steris

[Report Description]

The pharmaceutical analytical testing market is expected to register a CAGR of 6.5% over the forecast period. The key contributors in the market growth are focus on analytical testing of biologics and increasing number of clinical trials. According to the International Journal of Environmental Research and Public Health’s published study, around 40 medications are recalled per year in the United States and South Korea. This emerges the need for testing the products and ensure safety. Medicines are intended for better outcome in humans and animals. However, poor quality of medicines would not only affect adevrsely on the health of the patients but also on the fund systems. Therefore, to ensure safety and efficacy of the drugs analytical testing holds an important role.

Key Market Trends

Stability Testing Segment is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Statbility testing is done to evaluate the capability of the drug to retain it’s properties throughout it’s shelf-life. The stability testing is done on the basis of five parameters : Chemical, physical, microbiological, therapeutic and toxicity. The degredation with respect to any of these parameters can lead to health hazards. According to the study published by Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decaded. Furthermore, according to the World Health Organization, in 2019, the number of registered trials were around 92% in South East Asia and around 66% in the Eastern Mediterranean region. Hence, these factors are expected to impact positively on the market growth in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Pharmaceutical Analytical Testing market owing to increasing number of R&D activities and investments on it. According to the clinical, in 2019, around 293,321 studies were registered during the start of the year and around 32,523 at the end of year. Furthermore, in 2019, approximately 48 novel drugs were approved as per the data of the FDA's Center for Drug Evaluation and Research (CDER). According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies were around 79.6 billion USD in the United States. Thus, the increasing number of clinical trials and number of approved drugs is expected to boost up the demand of pharmaceutical analytical testing market growth in the North America Region.

Competitive Landscape

The Pharmaceutical Analytical Testing market consists of several interational as well as local companies. Some of the well-known companies in this market include Laboratory Testing Inc., Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc. and Steris

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Assumptions
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Clinical Trials
4.2.2 Focus on Analytical Testing of Biologics & Biosimilars
4.3 Market Restraints
4.3.1 Data Insecurity
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Test Type
5.1.1 Bioanalytical Testing Services
5.1.2 Method Development & Validation
5.1.3 Stability Testing
5.1.4 Drug Substances
5.1.5 Others
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.2.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Laboratory Testing Inc.
6.1.2 Eurofins Scientific
6.1.3 SGS SA
6.1.4 Toxikon Inc.
6.1.5 Pace Analytical Services
6.1.6 Intertek Phamaceutical Services
6.1.7 Boston Analytical
6.1.8 West Pharmaceutical Services Inc.
6.1.9 Steris




Recommended reports